Literature DB >> 22020322

Fibrin glue is a candidate scaffold for long-term therapeutic protein expression in spontaneously differentiated adipocytes in vitro.

Yasuyuki Aoyagi1, Masayuki Kuroda, Sakiyo Asada, Shigeaki Tanaka, Shunichi Konno, Masami Tanio, Masayuki Aso, Yoshitaka Okamoto, Toshinori Nakayama, Yasushi Saito, Hideaki Bujo.   

Abstract

Adipose tissue is expected to provide a source of cells for protein replacement therapies via auto-transplantation. However, the conditioning of the environment surrounding the transplanted adipocytes for their long-term survival and protein secretion properties has not been established. We have recently developed a preparation procedure for preadipocytes, ceiling culture-derived proliferative adipocytes (ccdPAs), as a therapeutic gene vehicle suitable for stable gene product secretion. We herein report the results of our evaluation of using fibrin glue as a scaffold for the transplanted ccdPAs for the expression of a transduced gene in a three-dimensional culture system. The ccdPAs secreted the functional protein translated from an exogenously transduced gene, as well as physiological adipocyte proteins, and the long viability of ccdPAs (up to 84 days) was dependent on the fibrinogen concentrations. The ccdPAs spontaneously accumulated lipid droplets, and their expression levels of the transduced exogenous gene with its product were maintained for at least 56 days. The fibrinogen concentration modified the adipogenic differentiation of ccdPAs and their exogenous gene expression levels, and the levels of exogenously transduced gene expression at the different fibrinogen concentrations were dependent on the extent of adipogenic differentiation in the gel. These results indicate that fibrin glue helps to maintain the high adipogenic potential of cultured adipocytes after passaging in a 3D culture system, and suggests that once they are successfully implanted at the transplantation site, the cells exhibit increased expression of the transduced gene with adipogenic differentiation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020322     DOI: 10.1016/j.yexcr.2011.10.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

Review 1.  The use of fat grafting and platelet-rich plasma for wound healing: A review of the current evidence.

Authors:  Oliver J Smith; Gavin Jell; Ash Mosahebi
Journal:  Int Wound J       Date:  2018-11-20       Impact factor: 3.315

Review 2.  Opportunities and challenges in three-dimensional brown adipogenesis of stem cells.

Authors:  Andrea M Unser; Yangzi Tian; Yubing Xie
Journal:  Biotechnol Adv       Date:  2015-07-29       Impact factor: 14.227

3.  Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system.

Authors:  Yoshitaka Fukaya; Masayuki Kuroda; Yasuyuki Aoyagi; Sakiyo Asada; Yoshitaka Kubota; Yoshitaka Okamoto; Toshinori Nakayama; Yasushi Saito; Kaneshige Satoh; Hideaki Bujo
Journal:  Exp Mol Med       Date:  2012-05-31       Impact factor: 8.718

4.  Fat grafting and platelet-rich plasma in wound healing: a review of histology from animal studies.

Authors:  Grant S Nolan; Oliver J Smith; Gavin Jell; Afshin Mosahebi
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

Review 5.  Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.

Authors:  William D Spotnitz
Journal:  ISRN Surg       Date:  2014-03-04

6.  Histological analysis of fat grafting with platelet-rich plasma for diabetic foot ulcers-A randomised controlled trial.

Authors:  Grant Switzer Nolan; Oliver John Smith; Susan Heavey; Gavin Jell; Afshin Mosahebi
Journal:  Int Wound J       Date:  2021-06-24       Impact factor: 3.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.